Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Semin Radiat Oncol. 2011 Oct;21(4):278–286. doi: 10.1016/j.semradonc.2011.05.007

Figure 3.

Figure 3

Radiographic assessment of treatment response. Worsening renal function due to underlying coronary artery disease and peripheral vascular disease prompted switching to non-contrast CT (4 months) and magnetic resonance imaging (beyond 4 months). Note durable local control with progressive reduction in tumor volume and vascularity with evolution of central tumor necrosis.